William R Strohl
Dr. William Strohl owns BiStro Biotech Consulting LLC, founded in 2016 to help biotechnology companies expand their capabilities. Prior to retiring from J&J in 2016, Dr. Strohl was VP, Janssen BioTherapeutics. Before J&J, Dr. Strohl was at Merck from 1997-2008, leading Natural Products Biology and, later, leading Biologics discovery efforts. From 1980-1997, Dr. Strohl rose from Assistant to Full Professor in the Department of Microbiology and Program of Biochemistry at Ohio State. Dr. Strohl has >140 publications, 17 patents, and wrote the book "Therapeutic Antibody Engineering: Current and Future Advances Driving the Strongest Growth Area in the Pharma Industry" (2012).
Abstract : Biobetters, they had better be better